F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
Posted inCIGNA Corporation CVS Caremark Corporation Drugs (Pharmaceuticals) Drugstores Express Scripts Inc Federal Trade Commission Health Insurance and Managed Care Insulin Khan, Lina Presidential Election of 2024 Prices (Fares, Fees and Rates) Regulation and Deregulation of Industry Suits and Litigation (Civil)

F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
Hot Summer Threatens Efficacy of Mail-Order Medications
Posted inCIGNA Corporation CVS Caremark Corporation Delivery Services Drugs (Pharmaceuticals) Express Scripts Inc Food and Drug Administration Heat and Heat Waves Insulin OptumRx Inc Regulation and Deregulation of Industry Weather your-feed-healthcare your-feed-science

Hot Summer Threatens Efficacy of Mail-Order Medications

The temperatures inside delivery trucks can reach twice the recommended threshold, but federal rules on drug storage conditions do not apply to the booming world of mail-order delivery.
F.T.C. Says Middlemen Seem to Drive Up Drug Prices
Posted inAntitrust Laws and Competition Issues CIGNA Corporation CVS Caremark Corporation Drugs (Pharmaceuticals) Drugstores Express Scripts Inc Federal Trade Commission Health Insurance and Managed Care Khan, Lina pharmacy benefit managers Prices (Fares, Fees and Rates) Regulation and Deregulation of Industry United States Politics and Government UnitedHealth Group Inc

F.T.C. Says Middlemen Seem to Drive Up Drug Prices

In a report, the regulator sharply criticized pharmacy benefit managers, a reversal from its longstanding hands-off approach to policing the companies.